{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:16:18Z","timestamp":1788430578510,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010846","name":"Health and Family Planning Commission of Hubei Province","doi-asserted-by":"publisher","award":["WJ2019Q002"],"award-info":[{"award-number":["WJ2019Q002"]}],"id":[{"id":"10.13039\/501100010846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010580","name":"Department of Science and Technology, Hubei Provincial People's Government","doi-asserted-by":"publisher","award":["2019CFC892"],"award-info":[{"award-number":["2019CFC892"]}],"id":[{"id":"10.13039\/501100010580","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00246-020-02470-4","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T20:02:30Z","timestamp":1602273750000},"page":"189-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cardiac Phenotype\u2013Genotype Associations in DMD\/BMD: A Meta-Analysis and Systematic Review"],"prefix":"10.1007","volume":"42","author":[{"given":"Huan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manli","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2445-6523","authenticated-orcid":false,"given":"Li","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"2470_CR1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","volume":"2","author":"F Muntoni","year":"2003","unstructured":"Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2:731","journal-title":"Lancet Neurol"},{"key":"2470_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"AE Emery","year":"1991","unstructured":"Emery AE (1991) Population frequencies of inherited neuromuscular diseases\u2013a world survey. Neuromuscul Disord Nmd 1:19","journal-title":"Neuromuscul Disord Nmd"},{"key":"2470_CR3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp.2007.141721","volume":"80","author":"M Kohler","year":"2009","unstructured":"Kohler M, Clarenbach CF, Bahler C, Brack T, Russi EW, Bloch KE (2009) Disability and survival in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 80:320","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2470_CR4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nmd.2010.09.006","volume":"21","author":"Y Ishikawa","year":"2011","unstructured":"Ishikawa Y, Miura T, Ishikawa Y, Aoyagi T, Ogata H, Hamada S, Minami R (2011) Duchenne muscular dystrophy: Survival by cardio-respiratory interventions. Neuromuscul Disorders Nmd 21:47","journal-title":"Neuromuscul Disorders Nmd"},{"issue":"13","key":"2470_CR5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0960-8966(02)00213-4","volume":"2003","author":"K Bushby","year":"2003","unstructured":"Bushby K, Muntoni F, Bourke JP (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002 Naarden, the Netherlands. Neuromuscul Disord 2003(13):166","journal-title":"Neuromuscul Disord"},{"key":"2470_CR6","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1161\/CIRCULATIONAHA.114.015151","volume":"131","author":"EM Mcnally","year":"2015","unstructured":"Mcnally EM, Kaltman JR, Woodrow Benson D, Canter CE, Cripe LH, Duan D, Finder JD, Hoffman EP, Judge DP, Kertesz N (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. Circulation 131:1590","journal-title":"Circulation"},{"key":"2470_CR7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ppul.23215","volume":"51","author":"DJ Birnkrant","year":"2016","unstructured":"Birnkrant DJ, Ararat E, Mhanna MJ (2016) Cardiac phenotype determines survival in Duchenne muscular dystrophy. Pediatr Pulmonol 51:70","journal-title":"Pediatr Pulmonol"},{"key":"2470_CR8","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","volume":"67","author":"F Kamdar","year":"2016","unstructured":"Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67:2533","journal-title":"J Am Coll Cardiol"},{"key":"2470_CR9","first-page":"329","volume":"12","author":"GF Cox","year":"1997","unstructured":"Cox GF, Kunkel LM (1997) Dystrophies and heart disease. Curr Opin Cardiol 12:329","journal-title":"Curr Opin Cardiol"},{"key":"2470_CR10","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1161\/01.CIR.94.12.3168","volume":"94","author":"P Melacini","year":"1996","unstructured":"Melacini P, Fanin M, Danieli GA, Villanova C, Martinello F, Miorin M, Freda MP, Miorelli M, Mostacciuolo ML, Fasoli G, Angelini C, Dalla VS (1996) Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 94:3168","journal-title":"Circulation"},{"key":"2470_CR11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/hrt.72.3.246","volume":"72","author":"M Burch","year":"1994","unstructured":"Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE (1994) Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 72:246","journal-title":"Br Heart J"},{"key":"2470_CR12","first-page":"368","volume":"330","author":"BA Berko","year":"1987","unstructured":"Berko BA, Swift M (1987) X-linked dilated cardiomyopathy. New Engl J Med 330:368","journal-title":"New Engl J Med"},{"key":"2470_CR13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCGENETICS.109.867242","volume":"2","author":"RW Kaspar","year":"2009","unstructured":"Kaspar RW, Allen HD, Ray WC, Alvarez CE, Kissel JT, Pestronk A, Weiss RB, Flanigan KM, Mendell JR, Montanaro F (2009) Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in Becker muscular dystrophy. Circ Cardiovasc Genet 2:544","journal-title":"Circ Cardiovasc Genet"},{"key":"2470_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","volume":"26","author":"G Nigro","year":"1990","unstructured":"Nigro G, Comi LI, Politano L, Bain RJI (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271","journal-title":"Int J Cardiol"},{"key":"2470_CR15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","volume":"14","author":"SV Raman","year":"2015","unstructured":"Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, Tran T, Smart S, Mccarthy B, Taylor MD (2015) Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: A randomised, double-blind, placebo-controlled trial. Lancet Neurol 14:153","journal-title":"Lancet Neurol"},{"key":"2470_CR16","first-page":"2c","volume":"5","author":"HD Allen","year":"2013","unstructured":"Allen HD, Flanigan KM, Thrush PT, Dvorchik I, Yin H, Canter C, Connolly AM, Parrish M, Mcdonald CM, Braunlin E (2013) A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy. PLoS Currents 5:2c","journal-title":"PLoS Currents"},{"key":"2470_CR17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjcard.2012.02.064","volume":"110","author":"L Viollet","year":"2012","unstructured":"Viollet L, Thrush PT, Flanigan KM, Mendell JR, Allen HD (2012) Effects of angiotensin-converting enzyme inhibitors and\/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy. Am J Cardiol 110:98","journal-title":"Am J Cardiol"},{"key":"2470_CR18","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.ijcard.2012.05.007","volume":"167","author":"SW Kwon","year":"2013","unstructured":"Kwon SW, Lee BK, Hong BK, Kim JY, Choi EY, Ji MS, Rhee JH, Park YM, Ma DW, Chung H (2013) Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients. Int J Cardiol 167:1990","journal-title":"Int J Cardiol"},{"key":"2470_CR19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00246-007-9113-z","volume":"29","author":"J Rhodes","year":"2008","unstructured":"Rhodes J, Margossian RB, Colan S, Jenkins K, Geva T, Powell A (2008) Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol 29:343","journal-title":"Pediatr Cardiol"},{"key":"2470_CR20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.amjcard.2006.04.020","volume":"98","author":"C Ramaciotti","year":"2007","unstructured":"Ramaciotti C, Heistein LC, Coursey M, Lemler MS, Eapen RS, Iannaccone ST, Scott WA (2007) Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. Am J Cardiol 98:825","journal-title":"Am J Cardiol"},{"key":"2470_CR21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nmd.2008.03.002","volume":"18","author":"LW Markham","year":"2008","unstructured":"Markham LW, Kinnett K, Wong BL, Woodrow BD, Cripe LH (2008) Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul Disord 18:365","journal-title":"Neuromuscul Disord"},{"key":"2470_CR22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s00246-005-0909-4","volume":"26","author":"LW Markham","year":"2005","unstructured":"Markham LW, Spicer RL, Khoury PR, Wong BL, Mathews KD, Cripe LH (2005) Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr Cardiol 26:768","journal-title":"Pediatr Cardiol"},{"key":"2470_CR23","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jpeds.2013.05.060","volume":"163","author":"BJ Barber","year":"2013","unstructured":"Barber BJ, Andrews JG, Zhenqiang L, West NA, John Meaney F, Price ET, Ashley G, Sheehan DW, Shree P, Michele Y (2013) Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy. J Pediatr-US 163:1080","journal-title":"J Pediatr-US"},{"key":"2470_CR24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pediatrneurol.2007.11.001","volume":"38","author":"S Houde","year":"2008","unstructured":"Houde S, Filiatrault M, Fournier A, Dub\u00e9 J, D'Arcy S, B\u00e9rub\u00e9 D, Brousseau Y, Lapierre G, Vanasse M (2008) Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 38:200","journal-title":"Pediatr Neurol"},{"key":"2470_CR25","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2012.12.008","volume":"61","author":"G Schram","year":"2013","unstructured":"Schram G, Fournier A, Leduc H, Dahdah N, Therien J, Vanasse M, Khairy P (2013) All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol 61:948","journal-title":"J Am Coll Cardiol"},{"key":"2470_CR26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jjcc.2009.02.001","volume":"53","author":"H Ogata","year":"2009","unstructured":"Ogata H, Ishikawa Y, Ishikawa Y, Minami R (2009) Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol 53:316","journal-title":"J Cardiol"},{"key":"2470_CR27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","volume":"154","author":"MC Herrera Enr\u00edquez","year":"2007","unstructured":"Herrera Enr\u00edquez MC (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 154:596","journal-title":"Am Heart J"},{"key":"2470_CR28","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.104.528281","volume":"112","author":"JL Jefferies","year":"2005","unstructured":"Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799","journal-title":"Circulation"},{"key":"2470_CR29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.amjcard.2014.04.038","volume":"114","author":"ML Ashwath","year":"2014","unstructured":"Ashwath ML, Jacobs IB, Crowe CA, Ashwath RC, Super DM, Bahler RC (2014) Left ventricular dysfunction in Duchenne muscular dystrophy and genotype. Am J Cardiol 114:284","journal-title":"Am J Cardiol"},{"key":"2470_CR30","first-page":"123","volume":"18","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman D (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Rev Espa\u00f1ola De Nutr Hum Y Diet\u00e9tica 18:123","journal-title":"Rev Espa\u00f1ola De Nutr Hum Y Diet\u00e9tica"},{"key":"2470_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/mus.26102","volume":"58","author":"RHD Cirino","year":"2018","unstructured":"Cirino RHD, Scola RH, Ducci RDP, Wermelinger ACC, Kay CSK, Lorenzoni PJ, Werneck LC, Carmes ER, Da CCLP (2018) Predictors of early left ventricular systolic dysfunction in Duchenne muscular dystrophy patients. Muscle Nerve 58:84","journal-title":"Muscle Nerve"},{"key":"2470_CR32","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.healun.2018.01.290","volume":"37","author":"K Gambetta","year":"2018","unstructured":"Gambetta K, Wittlieb-Weber C, Bock M, Villa C, Johnson J, Lal A, Schumacher K, Law S, Deshpande S, West S, Friedland-Little J, Lytrivi I, Butts R, Cunningham C, Knecht KR, McCullough M (2018) Impact of genotype on boys with Duchenne muscular dystrophy. J Heart Lung Transpl 37:S122","journal-title":"J Heart Lung Transpl"},{"key":"2470_CR33","first-page":"23","volume":"24","author":"E Martins","year":"2005","unstructured":"Martins E, Silva-Cardoso J, Silveira F, Nadais G, Rocha GF (2005) Left ventricular function in adults with muscular dystrophies: genotype-phenotype correlations. Rev Port Cardiol 24:23","journal-title":"Rev Port Cardiol"},{"key":"2470_CR34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jns.2017.08.2315","volume":"381","author":"K Nakamura","year":"2017","unstructured":"Nakamura K, Goto K, Ishikawa T, Shimazaki R, Matsubara E (2017) Genotype of early death due to cardiac failure in Duchenne muscular dystrophy. J Neurol Sci 381:823","journal-title":"J Neurol Sci"},{"key":"2470_CR35","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/humu.20841","volume":"29","author":"GD Del","year":"2008","unstructured":"Del GD, Yang Y, Boggs BA, Schmitt ES, Lee JA, Sahoo T, Pham HT, Wiszniewska J, Chinault AC, Beaudet AL, Eng CM (2008) Molecular diagnosis of Duchenne\/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization. Hum Mutat 29:1100","journal-title":"Hum Mutat"},{"key":"2470_CR36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmedgenet-2015-103387","volume":"53","author":"A Aartsma-Rus","year":"2016","unstructured":"Aartsma-Rus A, Ginjaar IB, Bushby K (2016) The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet 53:145","journal-title":"J Med Genet"},{"key":"2470_CR37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.24365","volume":"77","author":"AR Findlay","year":"2015","unstructured":"Findlay AR, Wein N, Kaminoh Y, Taylor LE, Dunn DM, Mendell JR, King WM, Pestronk A, Florence JM, Mathews KD, Finkel RS, Swoboda KJ, Howard MT, Day JW, McDonald C, Nicolas A, Le Rumeur E, Weiss RB, Flanigan KM (2015) Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45. Ann Neurol 77:668","journal-title":"Ann Neurol"},{"key":"2470_CR38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","volume":"154","author":"D Duboc","year":"2007","unstructured":"Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, B\u00e9cane H (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 154:596","journal-title":"Am Heart J"},{"key":"2470_CR39","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2169\/internalmedicine.49.3259","volume":"49","author":"T Matsumura","year":"2010","unstructured":"Matsumura T, Tamura T, Kuru S, Kikuchi Y, Kawai M (2010) Carvedilol can prevent cardiac events in Duchenne muscular dystrophy. Intern Med 49:1357","journal-title":"Intern Med"},{"key":"2470_CR40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C (2010) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9:177","journal-title":"Lancet Neurol"},{"issue":"2","key":"2470_CR41","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mus.24163","volume":"50","author":"H Kolski","year":"2014","unstructured":"Kolski H, Spurney C, Morgenroth PL, Shimizu R, Clemens RP (2014) Cooperative international neuromuscular research group Duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 50(2):250\u2013256","journal-title":"Muscle Nerve"},{"key":"2470_CR42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0960-8966(94)90073-6","volume":"4","author":"G Nigro","year":"1994","unstructured":"Nigro G, Politano L, Nigro V, Petretta VR, Comi LI (1994) Mutation of dystrophin gene and cardiomyopathy. Neuromuscul Disord 4:371","journal-title":"Neuromuscul Disord"},{"key":"2470_CR43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1590\/S0004-282X2007000100016","volume":"65","author":"AA Freund","year":"2007","unstructured":"Freund AA, Scola RH, Arndt RC, Lorenzoni PJ, Kay CK, Werneck LC (2007) Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach. Arq Neuropsiquiatr 65:73","journal-title":"Arq Neuropsiquiatr"},{"key":"2470_CR44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/mt.2008.264","volume":"17","author":"B Bostick","year":"2009","unstructured":"Bostick B, Yue Y, Long C, Marschalk N, Fine DM, Chen J, Duan D (2009) Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Therapy J Am Soc Gene Therapy 17:253","journal-title":"Mol Therapy J Am Soc Gene Therapy"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-020-02470-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-020-02470-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-020-02470-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T06:14:44Z","timestamp":1633846484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-020-02470-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2470"],"URL":"https:\/\/doi.org\/10.1007\/s00246-020-02470-4","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"2 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}